References
- Alaska Department of Environmental Conservation (2010). Sulfolane technical assistance and evaluation. Available from: https://www.scribd.com/document/75707499/Sulfolane-Report-Final [last accessed 17 Mar 2019].
- Andersen ME, Jones RA, Kurlansik L, et al. (1976). Sulfolane-induced convulsions in rodents. Res Commun Chem Pathol Pharmacol 15:571Jr.
- ATSDR (2010) ATSDR Health Consultation-Sulfolane (CAS No. 126-33-0).
- Black SR, Fennel TR, Mathews JM, et al. (2018). Disposition of [14C]hydroquinone in Harlan Sprague-Dawley rats and B6C3F1/N mice; species and route comparison. Xenibiotica 48:1128–41.
- Brown RP, Delp MD, Lindstedt SL, et al. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicology and Industrial Health 13:407–84.
- Brown VKH, Ferrigan LW, Stevenson DE. (1966). Acute toxicity and skin irritant properties of sulfolane. British Journal of Industrial Medicine 23:302–6.
- El-Serafi I, Terelius Y, Twelkmeyer B, et al. (2013). Gas chromatographic-mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci 913-914:98–105.
- El-Serafi I, Terelius Y, Abedi-Valugerdi M, et al. (2017). Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway. PLoS One 12:17.
- Gordon CJ, Long MD, Fehlner KS, Dyer RS. (1986). Sulfolane induced hypothermia enhances survivability in mice. Environ Res 40:92−7.
- Headley JV, Peru KM. (2002). LC/MS Determination of a Sulfolane Metabolite in Wetland Vegetation Exposed to Gas-Condensate Contaminated Ground Water. Commun Soil Sci Plant Anal 33:3457–68.
- HSDB (2006). Sulfolane. Hazardous Substances Data Bank 04/14/2006 ed. Bethesda, MD: National Library of Medicine (US).
- Huntingdon Life Sciences. (2001). Sulfolane toxicity study by oral administration via the drinking water to Cd rats for 13 weeks: Volume one. Huntingdon, England: Huntingdon Life Sciences Ltd. 653333. The study was peer-reviewed by three independent experts during the summer of 2011. The peer-review report is available upon request from STSC.
- Jung EC, Maibach HI. (2015). Animal models for percutaneous absorption. J Appl Toxicol 35:1–10.
- National Research Council (NRC) (2011). Guide for the Care and Use of Laboratory Animals, 8th edn. Washington, DC: National Academy Press.
- North Pole, AK Drinking Water Quality Report (2015). Available from: https://www.northpolealaska.com/sites/default/files/fileattachments/utilities/page/565/water_quality_report_2015.pdf [last accessed 17 Mar 2019].
- Novick RM, Mitzey AM, Brownfield MS, Elfarra A. (2009). Differential Localization of Flavin-Containing Monooxygenase (FMO) Isoforms 1, 3, and 4 in Rat Liver and Kidney and Evidence for Expression of FMO4 in Mouse, Rat, and Human Liver and Kidney Microsomes. J Pharmacol Exp Ther 329:1148–55.
- Organisation for Economic Co-operation and Development (OECD). (2004) Tetrahydrothiophene -1,1 dioxide, CAS No. 126-33-0. Geneva, Switzerland: UNEP Publications.
- Roberts JJ, Warwick GP. (1961). The mode of action of alkylating agents − III: The formation of 3-hydroxytetrahydrothiophene-1:1-dioxide from 1:4-dimethanesulphonyloxybutane (Myleran), S-β-L-alanyltetrahydrothiophenium mesylate, tetrahydrothiophene and tetrahydrothiophene-1:1-dioxide in the rat, rabbit and mouse. Biochem Pharmacol 6: 217–27.
- Ruppert PH, Dyer RS. (1985). Acute behavioral toxicity of sulfolane: influence of hypothermia. Toxicol Lett 28:111–6.
- U.S. EPA (Environmental Protection Agency) (2012) Provisional peer-reviewed toxicity values for sulfolane (CASRN 126-33-0). Available from: https://cfpub.epa.gov/ncea/pprtv/documents/Sulfolane.pdf
- Zhu ZH, Sun ML, Li ZS. (1987). An investigation of the maximum allowable concentration of sulfolane in surface water. Huaxi Yike Daxue Xuebao [J West China Univ Med Soc] 18:376−80.
- Zhu ZH, Gao N, Guo JT, et al. (1988). Studies on toxicokinetics of tritiated sulfolane in rat after oral administration. Huaxi Yike Daxue Xuebao [J West China Univ Med Soc] 19:61–4.